Henk Viëtor

MyLife Technologies BV develops ceramic microneedle arrays technology. The firm also offers tailor-made npMNA designs, which vary in needle and array dimensions, number of needles per array, and array cavities. The company was founded by Pieter Jan Vos, Regina Luttge and Henk Vietor in 2008 and is headquartered in Enschede, the Netherlands.

Oncodrone BV develops novel therapeutics for epithelial derived malignancies including prostate, breast, lung, pancreas and bladder cancer. It focuses on developing novel therapeutics for advanced cancer by targeting: Epithelial-to-Mesenchymal Transition (EMT) and Androgen Receptor (AR) Signaling. The company was founded in 2013 and is headquartered in Nijmegen, the Netherlands.

Skyline Diagnostics develops and commercializes diagnostic microarrays for oncology. These tests currently provide the healthcare professional diagnostic information using one comprehensive test and may be useful in the clinical management of patients with cancer. Skyline Diagnostics products are currently available research only tools in the United States. The development pipeline includes diagnostic tests for Acute Myeloid Leukemia, Multiple Myeloma, Acute Lymphatic Leukemia, and Brain tumors.

Vitol Solar I LLC produces and distributes solar energy, oil, and gas. The private company is based in Houston, TX. The company was founded in 1966 by Henk Viëtor and Jacques Detiger. The CEO is Dylan Seff.

Vitol Holding BV operates as a financial holding company with activities in the oil industry. The company was founded in 1966 and is headquartered in Rotterdam, the Netherlands.